Group Urges Specialized-Drug Imports Under New Philippines Law
This article was originally published in PharmAsia News
Executive Summary
The head of a Philippines drugstore association is urging the government to use the new Cheaper Medicines Act to focus on importing more specialized drugs not easily found in the country. The president of the Drugstores Association of the Philippines cited less-common drugs for treating cancer, which she said should be encouraged for patients who cannot afford more-expensive treatments. The Department of Health has said such expensive drugs may be included in the new law's maximum retail price provision if competition is considered unlikely to drive down prices. (Click here for more
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.